Phase 3 Clinical Trial of mRNA Vaccine Against Norovirus

Participants needed: Age 70+

*Please note that the buttons to live chat or learn more are not currently functional. You can reach out to us using the contact information listed at the bottom of this page.*

Study Purpose

This is a phase 3 study. We are looking to test the safety and effectiveness of mRNA-1403 vaccine for Norovirus.

About Norovirus

Norovirus is an infection that can cause sudden diarrhea and vomiting (commonly referred to as acute gastroenteritis). Symptoms may also include nausea, stomach pain, headache and chills, usually lasting for 1 to 3 days. In severe cases, these symptoms can lead to dehydration, which may require hospitalization or IV fluids.

What Does Participation Involve?

This study has 6 clinic visits and approximately 6 safety telephone calls over approximately 18 months. There are 3 study injections in the first 6 months.

You will be financially compensated for your time.

Am I Eligible?

You can take part in this study if:

• You are 70+ years of age
• In good health

Contact

Krystal Lariviere

Phone: 902-470-6574

Email: krystal.lariviere@iwk.nshealth.ca